[{"data":1,"prerenderedAt":47},["ShallowReactive",2],{"q-nurse-107-1-medical-surgical-014":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":22},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"freq":10},"nurse-107-1-內外科護理學-014","nurse-107-1-medical-surgical-014",107,1,14,"有關 C 型肝炎的治療，下列何者正確？",{"A":14,"B":15,"C":16,"D":17},"干擾素加上 Ribavirin 是目前標準治療模式","使用干擾素治療會使肝功能 ALT、AST 上升","Lamivudine 可抑制 C 型肝炎病毒 RNA 的複製","Lamivudine 副作用為體重增加、全血球數上升、亢奮","A",null,[],"本題考點是 C 型肝炎的藥物治療。依題目年代的標準治療模式，是以長效干擾素合併抗病毒藥 Ribavirin 來抑制 C 肝病毒複製，故A正確。B干擾素治療目標是抑制病毒使肝功能好轉，並非使 ALT、AST 上升，錯;C、D的 Lamivudine 為 B 型肝炎所用的核苷類反轉錄酶抑制劑，作用於 B 肝病毒 DNA 複製，並不抑制 C 肝病毒 RNA，其副作用描述亦不符，故C、D皆錯。",[23,27,31,35,39,43],{"webId":24,"stem":25,"number":10,"year":26,"session":10},"nurse-106-1-medical-surgical-001","有關巴金森氏病治療之敘述，下列何者正確？",106,{"webId":28,"stem":29,"number":30,"year":26,"session":10},"nurse-106-1-medical-surgical-002","有關巴金森氏病的護理指導，下列何者正確？",2,{"webId":32,"stem":33,"number":34,"year":26,"session":10},"nurse-106-1-medical-surgical-003","下列何者為出血性腦中風最主要的危險因子？",3,{"webId":36,"stem":37,"number":38,"year":26,"session":10},"nurse-106-1-medical-surgical-004","有關頸部脊髓損傷的神經性休克徵象，下列何者正確？",4,{"webId":40,"stem":41,"number":42,"year":26,"session":10},"nurse-106-1-medical-surgical-005","陳小姐診斷為腦下垂體腫瘤，進行經蝶骨腦下垂體切除術，術後出現尿崩症，下列敘述何者錯誤？",5,{"webId":44,"stem":45,"number":46,"year":26,"session":10},"nurse-106-1-medical-surgical-006","顱底骨折常出現的徵象，下列何者錯誤？",6,1783840740546]